View Future GrowthAuxly Cannabis Group 過去の業績過去 基準チェック /46Auxly Cannabis Groupは、平均年間41.7%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間9.4% 16.4%収益成長率で 成長しています。 Auxly Cannabis Groupの自己資本利益率は18.1%であり、純利益率は20.9%です。主要情報41.74%収益成長率45.32%EPS成長率Pharmaceuticals 業界の成長5.95%収益成長率16.40%株主資本利益率18.07%ネット・マージン20.94%前回の決算情報31 Mar 2026最近の業績更新お知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2026 Results on May 14, 2026Auxly Cannabis Group Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026お知らせ • Nov 06Auxly Cannabis Group Inc. to Report Q3, 2025 Results on Nov 13, 2025Auxly Cannabis Group Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 13, 2025お知らせ • Aug 06Auxly Cannabis Group Inc. to Report Q2, 2025 Results on Aug 14, 2025Auxly Cannabis Group Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 14, 2025お知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2025 Results on May 15, 2025Auxly Cannabis Group Inc. announced that they will report Q1, 2025 results at 9:30 AM, US Eastern Standard Time on May 15, 2025お知らせ • Mar 12Auxly Cannabis Group Inc. to Report Q4, 2024 Results on Mar 20, 2025Auxly Cannabis Group Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 20, 2025お知らせ • Oct 31Auxly Cannabis Group Inc. to Report Q3, 2024 Results on Nov 08, 2024Auxly Cannabis Group Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024すべての更新を表示Recent updatesお知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2026 Results on May 14, 2026Auxly Cannabis Group Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026お知らせ • Apr 28Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2026Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2026. Location: ontario, toronto Canadaお知らせ • Nov 06Auxly Cannabis Group Inc. to Report Q3, 2025 Results on Nov 13, 2025Auxly Cannabis Group Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 13, 2025お知らせ • Aug 06Auxly Cannabis Group Inc. to Report Q2, 2025 Results on Aug 14, 2025Auxly Cannabis Group Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 14, 2025お知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2025 Results on May 15, 2025Auxly Cannabis Group Inc. announced that they will report Q1, 2025 results at 9:30 AM, US Eastern Standard Time on May 15, 2025お知らせ • Apr 21Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2025Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2025. Location: ontario, toronto Canadaお知らせ • Mar 12Auxly Cannabis Group Inc. to Report Q4, 2024 Results on Mar 20, 2025Auxly Cannabis Group Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 20, 2025お知らせ • Oct 31Auxly Cannabis Group Inc. to Report Q3, 2024 Results on Nov 08, 2024Auxly Cannabis Group Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024お知らせ • Aug 08Auxly Cannabis Group Inc. to Report Q2, 2024 Results on Aug 15, 2024Auxly Cannabis Group Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 15, 2024お知らせ • May 09Auxly Cannabis Group Inc. to Report Q1, 2024 Results on May 13, 2024Auxly Cannabis Group Inc. announced that they will report Q1, 2024 results Pre-Market on May 13, 2024お知らせ • Apr 26Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024.お知らせ • Mar 19Auxly Cannabis Group Inc. to Report Q4, 2023 Results on Mar 25, 2024Auxly Cannabis Group Inc. announced that they will report Q4, 2023 results at 9:30 AM, US Eastern Standard Time on Mar 25, 2024お知らせ • Nov 07Auxly Cannabis Group Inc. to Report Q3, 2023 Results on Nov 13, 2023Auxly Cannabis Group Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 13, 2023お知らせ • Aug 09Auxly Cannabis Group Inc. to Report Q2, 2023 Results on Aug 14, 2023Auxly Cannabis Group Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 14, 2023お知らせ • Jul 28Auxly Cannabis Group Inc. Announces Executive ChangesAuxly Cannabis Group Inc. announced the resignation of Mr. Brian Schmitt from his position as Chief Financial Officer ("CFO") of Auxly, effective July 26, 2023. Mr. Schmitt is leaving for an opportunity outside of the cannabis industry at a non-reporting issuer. Travis Wong, Auxly's Senior Vice President of Finance, has been appointed interim CFO of Auxly effective immediately. Mr. Wong joined Auxly in 2017 and currently holds the position of Senior Vice President of Finance where he has been responsible for managing Auxly's day-to- day finance activities. Mr. Wong has more than 15 years of corporate finance, accounting and capital markets experience. Prior to joining Auxly, he worked as a natural resources investment banker at Nomura Securities based in London, England. He has advised on over $5bn of public and private M&A transactions and has been involved in capital raising transactions for a broad range of European corporations. Earlier in his career, he held positions at KPMG LLP in their audit and deal advisory teams. He is a Chartered Professional Accountant (CPA Canada), and holds a Bachelor of Business Administration from Simon Fraser University and an MBA from the University of Oxford.お知らせ • May 09Auxly Cannabis Group Inc. to Report Q1, 2023 Results on May 15, 2023Auxly Cannabis Group Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 15, 2023お知らせ • Feb 16Auxly Cannabis Group Inc. announced that it has received CAD 3.36 million in fundingOn February 15, 2023, Auxly Cannabis Group Inc. closed the transaction.お知らせ • Feb 11Auxly Cannabis Group Inc. announced that it expects to receive CAD 3.36 million in fundingAuxly Cannabis Group Inc. announced that it has entered into agreement with an institutional investor for a private placement to issue 96,000,000 common shares at a price of CAD 0.035 per common share and and 96,000,000 common share purchase warrants with each warrant entitling the investors to purchase one common share at an exercise price of CAD 0.045 per common share for gross proceeds of CAD 3,360,000 on February 10, 2023. The transaction is expected to close on February 13, 2023. The transaction is subject to all necessary regulatory approvals, including the approval of the Toronto Stock Exchange. The securities issuable upon the exercise of the warrants will be offered on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended, and certain other jurisdictions in accordance with applicable securities laws. No securities will be offered for sale or sold in Canada.お知らせ • Feb 03Morganti & Co. Issues Auxly Cannabis Group, Inc. Shareholder Class Action Notice of CertificationOn January 18, 2023, the Honourable Justice Morgan of the Ontario Superior Court of Justice certified the action: Relvas v. Auxly Cannabis Group Inc., Court File No.: CV-13-00617136-00CP (the Class Action) as a class proceeding against Auxly Cannabis Group Inc. and appointed Daniel Relvas as the representative plaintiff. The substance of the litigation has not been adjudicated by the Court (is that the Defendant made misrepresentations in its Management’s Discussion and Analysis and corresponding financial statement for the Three and Nine Months Ended September 30, 2018 on November 12, 2018, that were not publicly corrected until a news release on February 7, 2019). The Defendant denies the allegations. Class Members are automatically included in the action once certified if they do not opt-out. Investor do not need to do anything at this time to stay in the Class Action. If a settlement or any recovery or benefits are achieved for the Class and approved by the Court, investor will be notified about how to ask for the portion to which are entitled. Investor will be legally bound by all orders and judgments of the Court, and investor will not be able to sue the Defendant on investor own regarding the legal claims made in this case. Investor will NOT be required to pay any costs in the event that this Class Action is unsuccessful. All Class Members will be bound by all orders and judgments of the Court and any settlement reached unless they opt-out of the action. If investor wish to pursue own action or do not want to be bound by the outcome of the Class Action, then must opt-out of this Class Action and act prior to the expiration of the limitation periods.収支内訳Auxly Cannabis Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:CBWT.F 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費31 Mar 261593350031 Dec 251514249030 Sep 251464546030 Jun 251392843031 Mar 251302241031 Dec 24122-1641030 Sep 24115-7540030 Jun 24110-4541031 Mar 24102-6040031 Dec 23101-4540030 Sep 2399-740030 Jun 2390-9942031 Mar 2396-10148031 Dec 2294-13051030 Sep 2299-13354030 Jun 22104-8653031 Mar 2297-7549031 Dec 2184-4646030 Sep 2173-5342030 Jun 2161-5742031 Mar 2146-8142031 Dec 2047-8447030 Sep 2032-11649030 Jun 2021-11554031 Mar 2017-10253031 Dec 198-10350030 Sep 195-8053030 Jun 194-7252031 Mar 191-7052031 Dec 181-6748030 Sep 182-4144030 Jun 182-3833031 Mar 183-2724031 Dec 172-1818030 Sep 170-98030 Jun 170-34031 Mar 170-22031 Dec 16001030 Sep 16000030 Jun 16000031 Mar 16000031 Dec 15000030 Sep 15000030 Jun 150000質の高い収益: CBWT.FにはCA$6.3M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が31st March, 2026に影響を及ぼしています。利益率の向上: CBWT.Fの現在の純利益率 (20.9%)は、昨年(16.8%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: CBWT.F過去 5 年間で収益を上げており、収益は年間41.7%増加しています。成長の加速: CBWT.Fの過去 1 年間の収益成長率 ( 52.5% ) は、5 年間の平均 ( 年間41.7%を上回っています。収益対業界: CBWT.Fの過去 1 年間の収益成長率 ( 52.5% ) はPharmaceuticals業界-4.8%を上回りました。株主資本利益率高いROE: CBWT.Fの 自己資本利益率 ( 18.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 07:44終値2026/06/09 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Auxly Cannabis Group Inc. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Neal GilmerHaywood Securities Inc.Rahul SarugaserRaymond James Ltd.Venkata VelagapudiResearch Capital Corporation
お知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2026 Results on May 14, 2026Auxly Cannabis Group Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026
お知らせ • Nov 06Auxly Cannabis Group Inc. to Report Q3, 2025 Results on Nov 13, 2025Auxly Cannabis Group Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 13, 2025
お知らせ • Aug 06Auxly Cannabis Group Inc. to Report Q2, 2025 Results on Aug 14, 2025Auxly Cannabis Group Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 14, 2025
お知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2025 Results on May 15, 2025Auxly Cannabis Group Inc. announced that they will report Q1, 2025 results at 9:30 AM, US Eastern Standard Time on May 15, 2025
お知らせ • Mar 12Auxly Cannabis Group Inc. to Report Q4, 2024 Results on Mar 20, 2025Auxly Cannabis Group Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 20, 2025
お知らせ • Oct 31Auxly Cannabis Group Inc. to Report Q3, 2024 Results on Nov 08, 2024Auxly Cannabis Group Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024
お知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2026 Results on May 14, 2026Auxly Cannabis Group Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026
お知らせ • Apr 28Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2026Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2026. Location: ontario, toronto Canada
お知らせ • Nov 06Auxly Cannabis Group Inc. to Report Q3, 2025 Results on Nov 13, 2025Auxly Cannabis Group Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 13, 2025
お知らせ • Aug 06Auxly Cannabis Group Inc. to Report Q2, 2025 Results on Aug 14, 2025Auxly Cannabis Group Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 14, 2025
お知らせ • May 07Auxly Cannabis Group Inc. to Report Q1, 2025 Results on May 15, 2025Auxly Cannabis Group Inc. announced that they will report Q1, 2025 results at 9:30 AM, US Eastern Standard Time on May 15, 2025
お知らせ • Apr 21Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2025Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2025. Location: ontario, toronto Canada
お知らせ • Mar 12Auxly Cannabis Group Inc. to Report Q4, 2024 Results on Mar 20, 2025Auxly Cannabis Group Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 20, 2025
お知らせ • Oct 31Auxly Cannabis Group Inc. to Report Q3, 2024 Results on Nov 08, 2024Auxly Cannabis Group Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024
お知らせ • Aug 08Auxly Cannabis Group Inc. to Report Q2, 2024 Results on Aug 15, 2024Auxly Cannabis Group Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 15, 2024
お知らせ • May 09Auxly Cannabis Group Inc. to Report Q1, 2024 Results on May 13, 2024Auxly Cannabis Group Inc. announced that they will report Q1, 2024 results Pre-Market on May 13, 2024
お知らせ • Apr 26Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024.
お知らせ • Mar 19Auxly Cannabis Group Inc. to Report Q4, 2023 Results on Mar 25, 2024Auxly Cannabis Group Inc. announced that they will report Q4, 2023 results at 9:30 AM, US Eastern Standard Time on Mar 25, 2024
お知らせ • Nov 07Auxly Cannabis Group Inc. to Report Q3, 2023 Results on Nov 13, 2023Auxly Cannabis Group Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 13, 2023
お知らせ • Aug 09Auxly Cannabis Group Inc. to Report Q2, 2023 Results on Aug 14, 2023Auxly Cannabis Group Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 14, 2023
お知らせ • Jul 28Auxly Cannabis Group Inc. Announces Executive ChangesAuxly Cannabis Group Inc. announced the resignation of Mr. Brian Schmitt from his position as Chief Financial Officer ("CFO") of Auxly, effective July 26, 2023. Mr. Schmitt is leaving for an opportunity outside of the cannabis industry at a non-reporting issuer. Travis Wong, Auxly's Senior Vice President of Finance, has been appointed interim CFO of Auxly effective immediately. Mr. Wong joined Auxly in 2017 and currently holds the position of Senior Vice President of Finance where he has been responsible for managing Auxly's day-to- day finance activities. Mr. Wong has more than 15 years of corporate finance, accounting and capital markets experience. Prior to joining Auxly, he worked as a natural resources investment banker at Nomura Securities based in London, England. He has advised on over $5bn of public and private M&A transactions and has been involved in capital raising transactions for a broad range of European corporations. Earlier in his career, he held positions at KPMG LLP in their audit and deal advisory teams. He is a Chartered Professional Accountant (CPA Canada), and holds a Bachelor of Business Administration from Simon Fraser University and an MBA from the University of Oxford.
お知らせ • May 09Auxly Cannabis Group Inc. to Report Q1, 2023 Results on May 15, 2023Auxly Cannabis Group Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 15, 2023
お知らせ • Feb 16Auxly Cannabis Group Inc. announced that it has received CAD 3.36 million in fundingOn February 15, 2023, Auxly Cannabis Group Inc. closed the transaction.
お知らせ • Feb 11Auxly Cannabis Group Inc. announced that it expects to receive CAD 3.36 million in fundingAuxly Cannabis Group Inc. announced that it has entered into agreement with an institutional investor for a private placement to issue 96,000,000 common shares at a price of CAD 0.035 per common share and and 96,000,000 common share purchase warrants with each warrant entitling the investors to purchase one common share at an exercise price of CAD 0.045 per common share for gross proceeds of CAD 3,360,000 on February 10, 2023. The transaction is expected to close on February 13, 2023. The transaction is subject to all necessary regulatory approvals, including the approval of the Toronto Stock Exchange. The securities issuable upon the exercise of the warrants will be offered on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended, and certain other jurisdictions in accordance with applicable securities laws. No securities will be offered for sale or sold in Canada.
お知らせ • Feb 03Morganti & Co. Issues Auxly Cannabis Group, Inc. Shareholder Class Action Notice of CertificationOn January 18, 2023, the Honourable Justice Morgan of the Ontario Superior Court of Justice certified the action: Relvas v. Auxly Cannabis Group Inc., Court File No.: CV-13-00617136-00CP (the Class Action) as a class proceeding against Auxly Cannabis Group Inc. and appointed Daniel Relvas as the representative plaintiff. The substance of the litigation has not been adjudicated by the Court (is that the Defendant made misrepresentations in its Management’s Discussion and Analysis and corresponding financial statement for the Three and Nine Months Ended September 30, 2018 on November 12, 2018, that were not publicly corrected until a news release on February 7, 2019). The Defendant denies the allegations. Class Members are automatically included in the action once certified if they do not opt-out. Investor do not need to do anything at this time to stay in the Class Action. If a settlement or any recovery or benefits are achieved for the Class and approved by the Court, investor will be notified about how to ask for the portion to which are entitled. Investor will be legally bound by all orders and judgments of the Court, and investor will not be able to sue the Defendant on investor own regarding the legal claims made in this case. Investor will NOT be required to pay any costs in the event that this Class Action is unsuccessful. All Class Members will be bound by all orders and judgments of the Court and any settlement reached unless they opt-out of the action. If investor wish to pursue own action or do not want to be bound by the outcome of the Class Action, then must opt-out of this Class Action and act prior to the expiration of the limitation periods.